Tsumura & Co. (4540.T)
JPY 4759.0
(-0.69%)
JPY 4759.0
(-0.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 16.7 Billion JPY | 1.37% |
| 2022 | 16.48 Billion JPY | -12.5% |
| 2021 | 18.83 Billion JPY | 22.85% |
| 2020 | 15.33 Billion JPY | 11.38% |
| 2019 | 13.76 Billion JPY | -5.67% |
| 2018 | 14.59 Billion JPY | 0.61% |
| 2017 | 14.5 Billion JPY | 16.14% |
| 2016 | 12.48 Billion JPY | -0.55% |
| 2015 | 12.55 Billion JPY | -10.79% |
| 2014 | 14.07 Billion JPY | -22.02% |
| 2013 | 18.05 Billion JPY | 17.41% |
| 2012 | 15.37 Billion JPY | 14.46% |
| 2011 | 13.43 Billion JPY | 3.75% |
| 2010 | 12.94 Billion JPY | 20.94% |
| 2009 | 10.7 Billion JPY | -0.68% |
| 2008 | 10.77 Billion JPY | 17.92% |
| 2007 | 9.13 Billion JPY | -30.51% |
| 2006 | 13.15 Billion JPY | 6.24% |
| 2005 | 12.38 Billion JPY | 19.03% |
| 2004 | 10.4 Billion JPY | 22.67% |
| 2003 | 8.47 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 11.18 Billion JPY | 1910.79% |
| 2023 Q1 | 4.33 Billion JPY | 613.67% |
| 2023 Q4 | 556 Million JPY | -92.22% |
| 2023 FY | 16.7 Billion JPY | 1.37% |
| 2023 Q3 | 7.14 Billion JPY | 52.92% |
| 2023 Q2 | 4.67 Billion JPY | 7.87% |
| 2022 Q3 | 3.98 Billion JPY | -24.18% |
| 2022 FY | 16.48 Billion JPY | -12.5% |
| 2022 Q1 | 6.63 Billion JPY | 92.4% |
| 2022 Q2 | 5.25 Billion JPY | -20.73% |
| 2022 Q4 | 607 Million JPY | -84.77% |
| 2021 Q4 | 3.44 Billion JPY | -36.45% |
| 2021 FY | 18.83 Billion JPY | 22.85% |
| 2021 Q1 | 5.38 Billion JPY | 172.72% |
| 2021 Q2 | 4.57 Billion JPY | -15.09% |
| 2021 Q3 | 5.42 Billion JPY | 18.53% |
| 2020 Q4 | 1.97 Billion JPY | -62.53% |
| 2020 Q1 | 4.04 Billion JPY | 94.94% |
| 2020 Q2 | 4.03 Billion JPY | -0.17% |
| 2020 Q3 | 5.27 Billion JPY | 30.58% |
| 2020 FY | 15.33 Billion JPY | 11.38% |
| 2019 Q3 | 4.65 Billion JPY | 48.47% |
| 2019 FY | 13.76 Billion JPY | -5.67% |
| 2019 Q1 | 3.9 Billion JPY | 36.37% |
| 2019 Q2 | 3.13 Billion JPY | -19.7% |
| 2019 Q4 | 2.07 Billion JPY | -55.41% |
| 2018 Q2 | 3.56 Billion JPY | 1.42% |
| 2018 Q3 | 4.64 Billion JPY | 30.37% |
| 2018 Q4 | 2.86 Billion JPY | -38.44% |
| 2018 Q1 | 3.51 Billion JPY | 59.67% |
| 2018 FY | 14.59 Billion JPY | 0.61% |
| 2017 Q3 | 5.68 Billion JPY | 66.32% |
| 2017 Q2 | 3.42 Billion JPY | 7.08% |
| 2017 Q4 | 2.2 Billion JPY | -61.29% |
| 2017 Q1 | 3.19 Billion JPY | 141.06% |
| 2017 FY | 14.5 Billion JPY | 16.14% |
| 2016 FY | 12.48 Billion JPY | -0.55% |
| 2016 Q2 | 2.35 Billion JPY | -20.09% |
| 2016 Q3 | 5.85 Billion JPY | 148.07% |
| 2016 Q4 | 1.32 Billion JPY | -77.36% |
| 2016 Q1 | 2.95 Billion JPY | 54.07% |
| 2015 FY | 12.55 Billion JPY | -10.79% |
| 2015 Q4 | 1.91 Billion JPY | -53.3% |
| 2015 Q2 | 3.4 Billion JPY | 8.48% |
| 2015 Q3 | 4.1 Billion JPY | 20.61% |
| 2015 Q1 | 3.13 Billion JPY | 64.27% |
| 2014 Q4 | 1.9 Billion JPY | -68.38% |
| 2014 Q1 | 3 Billion JPY | -7.28% |
| 2014 Q2 | 3.12 Billion JPY | 3.93% |
| 2014 FY | 14.07 Billion JPY | -22.02% |
| 2014 Q3 | 6.03 Billion JPY | 93.34% |
| 2013 Q4 | 3.24 Billion JPY | -58.13% |
| 2013 FY | 18.05 Billion JPY | 17.41% |
| 2013 Q1 | 3.8 Billion JPY | 18.45% |
| 2013 Q2 | 3.26 Billion JPY | -14.32% |
| 2013 Q3 | 7.74 Billion JPY | 137.28% |
| 2012 Q1 | 3.8 Billion JPY | -9.42% |
| 2012 Q4 | 3.21 Billion JPY | -39.07% |
| 2012 Q2 | 3.07 Billion JPY | -19.18% |
| 2012 Q3 | 5.27 Billion JPY | 71.43% |
| 2012 FY | 15.37 Billion JPY | 14.46% |
| 2011 Q4 | 4.2 Billion JPY | 2.84% |
| 2011 FY | 13.43 Billion JPY | 3.75% |
| 2011 Q1 | 3.59 Billion JPY | 15.0% |
| 2011 Q3 | 4.08 Billion JPY | 164.53% |
| 2011 Q2 | 1.54 Billion JPY | -57.04% |
| 2010 Q1 | 3.18 Billion JPY | 52.27% |
| 2010 Q3 | 3.9 Billion JPY | 43.27% |
| 2010 Q4 | 3.12 Billion JPY | -19.9% |
| 2010 FY | 12.94 Billion JPY | 20.94% |
| 2010 Q2 | 2.72 Billion JPY | -14.5% |
| 2009 FY | 10.7 Billion JPY | -0.68% |
| 2009 Q4 | 2.09 Billion JPY | -40.18% |
| 2009 Q3 | 3.49 Billion JPY | 41.32% |
| 2009 Q2 | 2.47 Billion JPY | -6.0% |
| 2009 Q1 | 2.63 Billion JPY | -4.74% |
| 2008 Q4 | 2.76 Billion JPY | -7.18% |
| 2008 Q2 | 2.47 Billion JPY | 0.0% |
| 2008 FY | 10.77 Billion JPY | 17.92% |
| 2008 Q3 | 2.97 Billion JPY | 20.51% |
| 2007 FY | 9.13 Billion JPY | -30.51% |
| 2006 FY | 13.15 Billion JPY | 6.24% |
| 2005 FY | 12.38 Billion JPY | 19.03% |
| 2004 FY | 10.4 Billion JPY | 22.67% |
| 2003 FY | 8.47 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -421.279% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 88.403% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 105.304% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 89.689% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -15233.291% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 35.372% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -108.187% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 60.603% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -2296.987% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | -19.601% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -267.429% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -1113.29% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 9381.667% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | -49.704% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -305.608% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | -3.302% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -386.376% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -116.097% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -213.923% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 441.377% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -407.041% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 951.175% |
| MedRx Co., Ltd | -932 Million JPY | 1892.597% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -342.659% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 1602.428% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 798.505% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -121.431% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | -21.993% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 2935.487% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 19.122% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -467.043% |